EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer BeitragOpen Access · CC BY 4.0

Control of human Q fever by vaccination: the journey to Q-VAX and beyond

Robert A Heinzen iD, Kathleen N Pierce iD, Daniel E Voth iD, John Stenos iD, Stephen Graves, Carrie Mae Long iD

Infection and Immunity · 2025

DOI: 10.1128/iai.00280-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Infection and Immunity, 2025. Verfasst von Robert A Heinzen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Bacteriology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Ham…. Hauptthemen laut MEDLINE: Bacterial Vaccines, Coxiella burnetii, Q Fever, Vaccination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Division of Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current vaccine development efforts encompass diverse and innovative approaches; however, studies with basic vaccines (e.g., whole cell inactivated) continue to inform these efforts. Perhaps the world’s most effective and durable human vaccine, the query (Q) fever vaccine known as Q-VAX, can trigger a severe post-vaccination hypersensitivity reaction, precluding its widespread deployment. The history of Q fever vaccine development serves as a rich example of the power of scientific collaboration, elegant experimentation, and the study of adverse post-vaccination events. Here, we review the history of Q fever vaccine development, profiling seminal studies while also relating this information to modern vaccine development efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacterial VaccinesCoxiella burnetiiQ FeverVaccinationAnimalsHumansHistory, 20th CenturyHistory, 21st CenturyVaccine Development

Stichwörter der Autor:innen

Coxiella burnetiiQ feverQ-VAXbacterial vaccinehistoryhuman vaccinationvaccine

Substanzen

Bacterial Vaccines

Autor:innen und Institutionen

  • Laboratory of Bacteriology, Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health, Hamilton, Montana, USA.
  • Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Australian Rickettsial Reference Laboratory, Barwon Health, Geelong, Victoria, Australia.

ORCID-Profile: Robert A Heinzen, Kathleen N Pierce, Daniel E Voth, John Stenos, Carrie Mae Long

Förderung

  • NHLBI NIH HHS
  • Division of Intramural Research

Zitieren

APA

Heinzen, R. A., Pierce, K. N., Voth, D. E., Stenos, J., Graves, S., & Long, C. M. (2025). Control of human Q fever by vaccination: the journey to Q-VAX and beyond. Infection and Immunity. https://doi.org/10.1128/iai.00280-25

Vancouver

Heinzen RA, Pierce KN, Voth DE, Stenos J, Graves S, Long CM. Control of human Q fever by vaccination: the journey to Q-VAX and beyond. Infection and Immunity. 2025. doi:10.1128/iai.00280-25

BibTeX
@article{Heinzen2025,
  author = {Heinzen, Robert A and Pierce, Kathleen N and Voth, Daniel E and Stenos, John and Graves, Stephen and Long, Carrie Mae},
  title = {Control of human Q fever by vaccination: the journey to Q-VAX and beyond},
  journal = {Infection and Immunity},
  year = {2025},
  doi = {10.1128/iai.00280-25}
}
Kostenlos starten →